Wanbury Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,09,844 shares,. Its Average Traded Price (ATP) is ₹195.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 61 @ ₹193.46.
Wanbury has an upper circuit limit of ₹232.15 and a lower circuit limit of ₹154.77. The total value traded stands at ₹2.14 CR, and the delivery percentage for the day is 37.84%.
The stock is currently traded with a market lot size of 1. Wanbury also offers a dividend yield of 0%.
Wanbury Share Price Chart
Wanbury Share Key Metrics
Volume
1.10 L
Market Cap
676.47 CR
LTQ@LTP
61@193.46
ATP
195.16
Var Margin
25.32 %
Circuit Range
154.77-232.15
Delivery %
37.84 %
Value
2.14 CR
ASM/GSM
No
Market Lot
1
Wanbury Resistance and Support
Pivot 201.05
Resistance
First Resistance
206.1
Second Resistance
212.25
Third Resistance
217.3
Support
First Support
194.9
Second Support
189.85
Third Support
183.7
Wanbury Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Wanbury Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-05-15 | Audited Results |
| 2025-02-12 | Quarterly Results & Others |
| 2024-08-12 | Quarterly Results |
Wanbury News
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury Limited has secured regulatory approval from ANVISA (Brazil FDA) for its flagship API, Metformin HCl EP grade. This marks the company's third consecutive approval from ANVISA, enabling customers to use its APIs for formulations.
Nov 12 2026 11:27:22
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury received a GMP Compliance Certificate from Australia's TGA for its Tanuku manufacturing facility. The approval covers six APIs and is valid until 9 Dec 2028, enabling supply to the Australian market.
Oct 30 2026 13:02:34
Wanbury Ltd - 524212 - Board Meeting Intimation for Wanbury Limited Is Scheduled To Be Held On Wednesday, November 04, 2026 Inter-Alia, To Consider And Approve The Un-Audited Financial Results (Standalone & Consolidated) For The Second Quarter And Half Year Ended September 30, 2026.
Wanbury board of directors will meet on 04 November 2026 to consider financial results for the quarter ended 30 September 2026.
Oct 28 2026 15:23:31
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury received 11 'No DMF Deficiency' letters from the USFDA for its APIs including Metformin HCl. The company also announced new business in Saudi Arabia and Mexico with an annual revenue potential of Rs.10 crore and Rs.15 crore, respectively.
Oct 16 2026 13:12:35
Wanbury Management
| Name | Position |
|---|---|
| K Chandran | Whole Time Director |
| Mohan Kumar Rayana | Whole Time Director |
Wanbury Similar Stocks
Shree Ganesh Remedies Ltd.
657.95
14.65 (2.28%)
Gaudium IVF and Women Health Ltd.
106.14
-1.46 (1.36%)
Amanta Healthcare Ltd.
234.47
6.10 (2.67%)
Hexagon Nutrition Ltd.
58.70
-1.21 (2.02%)
Zim Laboratories Ltd.
140.89
-0.13 (0.09%)
Kilitch Drugs (India) Ltd.
215.11
14.50 (7.23%)
Osel Devices Ltd.
384.35
-3.40 (0.88%)
Kaya Ltd.
342.20
-6.95 (1.99%)
Valiant Laboratories Ltd.
104.96
-2.14 (2.00%)
Influx Healthtech Ltd.
280.25
12.30 (4.59%)
Wanbury FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in WANBURY
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC